ArticleDiscover oncology2025
Pulmonary metastasis of giant cell tumor of bone 29 years after local recurrence resection: implications for Long-Term surveillance.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- β-Human Chorionic Gonadotropin-Secreting Giant Cell Tumor of Bone in the Mandible: Case Report and Comprehensive Literature Review.Head and neck pathology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary metastases of giant cell tumor of bone (GCTB) are rare and typically occur within several years of initial diagnosis or local recurrence. Here, we report a case with the longest documented interval-29 years-between the last local recurrence of GCTB and pulmonary metastasis, highlighting the need for long-term surveillance. CASE PRESENTATION: A 52-year-old female presented with an incidental pulmonary nodule detected 29 years after wide resection of recurrent GCTB in the left humeral head. Initial suspicion of primary lung cancer led to thoracoscopic lobectomy, which identified the nodule as a giant cell tumor through histopathological examination. Immunohistochemistry confirmed the diagnosis. This case emphasizes the potential for extremely delayed metastases of GCTB, likely due to the slow-growing nature of metastatic lesions. The findings underscore the challenges of distinguishing metastatic GCTB from primary lung cancers, which may result in overtreatment.
conclusionThis report underscores the necessity of long-term surveillance for high-risk GCTB patients, even decades after treatment. It also highlights the unique biology of GCTB metastases, warranting further research into mechanisms and tailored management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.